Cargando…
MicroRNA-103 regulates the progression in endometrial carcinoma through ZO-1
Endometrial carcinoma (EC) is one of the most common gynecological cancers in many developing countries. Although tremendous advances have been made in the diagnosis and treatment of EC, there is still no adequate biomarker currently available for predicting the prognosis of this cancer. In this stu...
Autores principales: | Du, Jing, Zhang, Fengli, Zhang, Ling, Jia, Yueyue, Chen, Huixiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713959/ https://www.ncbi.nlm.nih.gov/pubmed/31456452 http://dx.doi.org/10.1177/2058738419872621 |
Ejemplares similares
-
MicroRNA-103 regulates tumorigenesis in colorectal cancer by targeting ZO-1
por: Ke, Jin, et al.
Publicado: (2018) -
Induction of microRNA resistance and secretion in differentiating human endometrial stromal cells
por: Shah, Kunal M., et al.
Publicado: (2013) -
An investigation of microRNA‐103 and microRNA‐107 as potential blood‐based biomarkers for disease risk and progression of Alzheimer's disease
por: Wang, Jie, et al.
Publicado: (2019) -
Evaluation of plasma exosomal microRNAs as circulating biomarkers for progression and metastasis of gastric cancer
por: Chen, Yuqi, et al.
Publicado: (2020) -
The MicroRNA-200 Family Is Upregulated in Endometrial Carcinoma
por: Snowdon, Jaime, et al.
Publicado: (2011)